Big Price Increase for TB Drug Is Rescinded
Monday, September 21, 2015 - 18:50
in Mathematics & Economics
Rodelis, which acquired cycloserine and promptly raised its price more than twentyfold, returned it to the foundation that had previously owned the drug.